Pregnancy is one of the most important events of a woman's life, in which biological and psychosocial changes are experienced simultaneously. Studies show that the positive feelings experienced in this period are accompanied by negative feelings such as concern, stress, and fear and that the health of both the mother and the baby declines and psychiatric disorders emerge.[@ref1]-[@ref3] According to the literature, the fear and anxiety mainly originate from the delivery due to factors such as labor pain, obstetric damage, emergency cesarian section, possible complications, death, inability to perform motherhood tasks, concern of survival during labor, concern for the baby's health, lack of trust in the health personnel, and more.[@ref4]-[@ref6] A study conducted by Adams et al[@ref7] on 2206 women who had planned vaginal deliveries reported that interventional procedures (epidural analgesia, labor induction, labor augmentation) were necessary in 17% of women who feared childbirth and 10.9% of these took place compulsorily with a cesarean section. Midwives, who play an active role in the management of delivery, must handle the anxiety and fear related with childbirth while providing observation and care for the pregnant woman in labor. Effective care during this process constitutes the basis of midwifery in the intrapartum period. However, assessment of fear and anxiety may be overlooked during labor.[@ref8]-[@ref10] In line with this information, the anxiety of pregnant women must be determined especially in the labor period due to the fear, anxiety, and secondary problems experienced during delivery. Although there are scales developed to determine the anxiety during the pregnancy and postpartum periods, scales such as State-Trait Anxiety Inventory (STAI), Visual Analogue Scale (VAS), Impact of Event Scale (IES) and Wijma-Delivery Expectancy-Experience Scale (W-DEQ) are generally used for measuring anxiety at the time of delivery.[@ref11]-[@ref16] However, none specific questions to measure anxiety during delivery were included. Therefore, the objective of this study was to develop a valid and reliable measurement tool that will facilitate determining anxiety levels of pregnant women coming to the hospital for childbirth at an early period during labor and to contribute to ensuring provision of necessary midwifery care.

Methods {#sec1-2}
=======

This study involves methodological research for developing an Anxiety Assessment Scale for Pregnant Women in Labor (AASPWL) and descriptive research for determining the anxiety level of pregnant women in labor.

The study was conducted in 2 sections. The first section examines the scope, validity, and reliability of the scale while the second section investigates the relationship with the previously used Beck Anxiety Scale.[@ref17]

Section 1. Scale development. Drafting of the items and expert's opinion {#sec2-1}
------------------------------------------------------------------------

A question pool of 17 items was prepared with special attention paid to ensuring that the scale questions were clear, comprehensible, and relevant to the subject. Expert's opinions were obtained to determine whether the items of the measurement instrument were suitable for the measurement objective and whether they were representative of the area intended to be measured. The scale form was presented to 19 experts for evaluation (10 from the Gynecology and Obstetrics Nursing Department, 7 from the Psychiatry Nursing Department, one expert in the Turkish Language, and one expert in Statistics). In line with the opinions of the experts, the scale form was finalized to 9 items, which were scored from 1-5. Reverse (symmetrical) coding was applied to the positive questions so as to ensure similar scoring and interpretation of each item. Total score of the AASPWL was calculated by dividing the scores from the answers given to the 9 items of the scale into the number of questions. A high mean score for the scale and sub-dimension (5-point scale: highest = 5 points, lowest = one point) indicates that the anxiety of pregnant women in labor is affected negatively.

Written informed consent was obtained from the management of the related institution of the study sample and Research Ethics Committee's Approval was obtained from the Sakarya Faculty of Medicine, prior to study commencement. The objective and period of the study were explained to the pregnant women along with the expectations of them, and their informed consent was obtained on a voluntary basis. Actions were taken in line with the rules set forth in the Helsinki Declaration during the data collection stage.

Application of the scale {#sec2-2}
------------------------

The population of this study was consisted by pregnant women (n=2000) enrolled at a Public Hospital in Sakarya, Turkey between November 2016 and July 2017. Individuals with a high-risk pregnancy, chronic illness, psychiatric problems, and communication issues were not included in the study. The number of pregnant women enrolled in the study sample was 269 using the simple random sampling formula. The scale was applied during admission to the labor room before any intervention was required. A draft of the scale was applied to 20 individuals in a pilot study and then evaluated for comprehensibility and amended to include any necessary revisions.

Validity and reliability analysis of the scale {#sec2-3}
----------------------------------------------

The expert's opinions and a factor analysis were applied to determine the validity. A test-retest analysis and Cronbach's alpha analysis were applied to establish reliability. Examination of the factors' structures included a confirmatory factor analysis (CFA) with 119 people and an exploratory factor analysis (EFA) with 150 people. The test-retest method was not applied as the scale was developed to assess the anxiety of pregnant women during delivery.

Section 2 - Relationship analysis for the AASPWL and BAI scales {#sec2-4}
---------------------------------------------------------------

Correlation analyses were performed following establishment of a model to determine the relationship effects between the AASPWL that is developed and the BAI that was used previously.

Data analysis {#sec2-5}
-------------

Data was transferred to the IBM SPSS Statistics 23 and IBM SPSS AMOS 23 (Armonk, NY, USA) programs. In an evaluation of the study data, the distribution of the sample mean approached normal distribution for n→∞ in numeric variables according to the Law of Large Numbers.[@ref18] Descriptive statistics (number and percentage) were provided for the categorical variables. Expert's opinions were evaluated with the Kendall's W test. Statistically, values *p*\<0.05 were considered to be significant.

Results {#sec1-3}
=======

Examination of the AASPWL sub-dimensions and the mean total points revealed that anxiety is at a high level for pregnant women in labor (3.54±3.56). The highest anxiety score was found in the motherhood constellation sub-dimension (4.11±4.33) (**[Table 1](#T1){ref-type="table"}**).

###### 

Descriptive data for the scale questions (n=269).
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Section 1 - AASPWL development analysis. Content validity {#sec2-6}
---------------------------------------------------------

Eight items with an index below 0.80 were deleted in line with the opinions of the 19 experts (decreased to nine items), and no further problems in the scale's content were observed. The Kendall's W concordance test revealed no significant differences between the opinions of the experts (W=0.090; *p*=0.080). The final scale consisted of 2 sub-dimensions and a total of 9 items, of which 6 are in the birth process sub-dimension and 3 were in motherhood constellation sub-dimension and was found to be statistically valid and reliable.

Scale validity {#sec2-7}
--------------

Exploratory factor analysis and CFA were used to determine the construct validity of the scale. The Kaiser-Meyer-Olkin (KMO) and Bartlett's sphericity tests were used to test the suitability of the data to the sampling group and adequacy of the sampling prior to the construct validity analyses. The KMO coefficient over 0.60 and the significant output of the Bartlett test indicate that the data was suitable for further factor analysis.[@ref19] In this study, the KMO value was found to be 0.781; thus, the factor analysis results to be applied to the data were useful and useable. The Bartlett's sphericity test indicated significantly high relationships between the variables and that the data was suitable for the factor analysis (*x^2^*: 353,813, SD: 36, *p*=0.000).

Confirmatory factor analysis was used to assess information on the quality of the main factors determined by EFA, general structure of the scale, and the level at which the scale explained anxiety during labor.

Exploratory factor analysis (EFA) {#sec2-8}
---------------------------------

Exploratory factor analysis was applied to this data set to determine the construct validity of the scale and establish the dimensioning factor loads of the items included in the scale, and "Principal Components Method" was the preferred factor extraction method. No limitations were imposed on factor number. Statements with factor loads over 0.50 were included. While the birth process sub-dimension explained 35.1% of the total AASPWL variance, the motherhood constellation sub-dimension explained 18.8%. Together, these 2 sub-dimensions explained 53.9% of the total variance (n=150). The cut-off point was 0.50 in the scale analysis and all items remained over 0.50. Overall, the factor loads of the 9 items were found to vary between 0.63 and 0.83 (**[Table 2](#T2){ref-type="table"}**).
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Scale factor loads (n=150).
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Confirmatory factor analysis {#sec2-9}
----------------------------

In the first stage, a first degree CFA model was created, in which 2 factor-dimensions were included as latent variables and the statements forming these factors were included as indicator variables (n=119) (**[Figure 1](#F1){ref-type="fig"}**). The maximum likelihood method, which is frequently used in structural equation modeling and gives reliable results even in conditions without normal distribution, was used in the second phase of model estimation. The aim was to estimate the errors of the observable variables, variances of the latent variables, and parameters covering the regression coefficients related to the paths drawn from the observable variables to the latent variables.

![First order confirmatory factor analysis modeling with 2 sub-dimensions. AASPWL - Anxiety Assessment Scale for Pregnant Women in Labor](SaudiMedJ-39-609-g003){#F1}

Fit indexes for the first order CFA model with 2 sub-dimensions were examined in the final stage. Examination of the findings in **[Table 3](#T3){ref-type="table"}** revealed that the structure of 2 factors of the scale has a good fit. Moreover, there was a positive but small relationship (r=0.26) between the sub-dimensions. Examination of the fit values revealed that the Chi square/degree of freedom (*x^2^*/df: 1.737), root mean square error of approximation (RMSEA: 0.079), and standardized root mean square residue (SRMR: 0.080) values were acceptable; while the incremental fit index (IFI: 0.860), Tucker-Lewis index (TLI: 0.780), and comparative fit index (CFI: 0.847) values were unacceptable.[@ref20]-[@ref22] In general, the AASPWL was found to be acceptable upon evaluation of the fit indexes.
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Standard regression coefficients of 119 participants.

![](SaudiMedJ-39-609-g004)

###### 

Examination of the relationship between Anxiety Assessment Scale for Pregnant Women in Labor and the Beck Anxiety Scale (n=269).
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Scale reliability {#sec2-10}
-----------------

Internal consistency analysis was performed and Cronbach's alpha value calculated for the reliability of the developed AASPWL was found to be 0.77. Moreover, the values remained between 0.73 and 0.78 when Cronbach's alpha values were examined individually when each item in the scale was removed. These results indicate consistency between the items constituting the developed scale, the characteristic intended to be measured, and that there is a high level of connection between all scale items in terms of consistency.

Section 2. Relationship analysis for the AASPWL and BAI scales {#sec2-11}
--------------------------------------------------------------

The relationship between the developed scale and the BAI, previously used to measure anxiety during labor, was examined. Cronbach's alpha value for the BAI was calculated as 88.9. An acceptable Cronbach's alpha value higher than 0.70 was found for the AASPWL and BAI.[@ref23] The Pearson correlation analysis revealed a moderate level (36.9%) of a statistically significant positive relationship was found between the AASPWL and BAI (*p*\<0.05).

Discussion {#sec1-4}
==========

In this study, we developed a 9-item AASPWL with 2 conceptual sub-dimensions to measure anxiety during labor. The first sub-dimension covered anxiety related to the birth process, called "birth process" and the second covered anxiety related to motherhood, called "motherhood constellation." "Motherhood constellation" is a term from the literature coined by Daniel Stern that refers to the new and unique arrangement of a woman's mental structure after the birth of her baby. It covers the concern of the mother related to the survival and growth of her baby, safe bonding between the mother and the baby, characteristics of a supportive environment, and rearrangement of the mother's character starting with pregnancy.[@ref24] The application of the AASPWL in this study revealed high anxiety among expectant mothers in the general mean score. This broke down into high anxiety levels from the motherhood constellation sub-dimension and medium anxiety levels from the birth process sub-dimension (**[Table 1](#T1){ref-type="table"}**).

The correlation analysis applied between the AASPWL and the BAI found a statistically significant moderate relationship (r=0.369). In the literature, Beck et al[@ref17] reported a relationship of r=0.51 between the BAI and the Hamilton Anxiety Scale. A significant relationship is found between BAI and STAI TX-1 (State) at a rate of r=0.61 and between BAI and STAI TX-2 (Trait) at a rate of r=0.59 (*p*\<0.001) in a study by Avci.[@ref25] A very strong relationship was also observed between BAI and State-Trait Anxiety Inventory (STAI) (r=0.47-0.58).[@ref12] The relationship in our study is slightly lower than those from the literature, likely due to the BAI's focus on somatic symptoms while the AASPWL is designed for pregnant women in labor. However, the absence of a negative relationship between the developed AASPWL and BAI and the presence of a statistically significant positive and moderate relationship, confirm that our scale successfully measures anxiety.

In conclusion, the AASPWL developed in this study aptly assess the anxiety of pregnant women in labor. The statistical analyses establish that the AASPWL is a useful tool for determining anxiety levels in scientific research and a reliable and valid scale for assessing anxiety levels of women in labor. Although there are many scales that assess anxiety, stress, and depression, there are no specific scales for pregnant women in labor. Furthermore, the labor phase is a difficult and painful process for women. Thus, conciseness of the AASPWL (9 items) represents an advantage for this particular application (pregnant women in labor). Moreover, the scale is well suited to contribute to the literature in terms of mother-infant health and well-being because it contains questions specific to both the mother and the infant that may be informative beyond the labor. Future studies include: examination of different studies in which the AASPWL is used, translation of the AASPWL into different languages, and application to pregnant women in labor in different cultures to assess its effectiveness.

There are a few limitations to this study. The main limitation of this study is that only primipar pregnants who have spontaneous vaginal deliveries are included. The study was conducted in Sakarya in Turkey. Thus, these results may not reflect the whole country.
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